Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Sees Large Decrease in Short Interest

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI – Get Rating) was the target of a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 2,870,000 shares, a decline of 9.2% from the April 30th total of 3,160,000 shares. Approximately 9.5% of the company’s stock are short sold. […]